Councilmark Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.91M Hold
11,137
– – 1.5% 18
2026
Q2
$2.8M Hold
11,137
– – 1.48% 19
2026
Q1
$2.42M Buy
11,137
+20
+0.2% +$4.44K 1.39% 19
2025
Q4
$2.54M Sell
11,117
-147
-1% -$33.5K 1.42% 18
2025
Q3
$2.61M Hold
11,264
– – 1.5% 18
2025
Q2
$2.09M Sell
11,264
-38
-0.3% -$7.06K 1.32% 22
2025
Q1
$2.37M Hold
11,302
– – 1.6% 19
2024
Q4
$2.01M Hold
11,302
– – 1.35% 21
2024
Q3
$2.23M Hold
11,302
– – 1.5% 19
2024
Q2
$1.94M Hold
11,302
– – 1.37% 20
2024
Q1
$2.06M Buy
+11,302
New +$1.95M 1.48% 19

Other funds holding ABBV

Councilmark Asset Management's ABBV Position: Q3 2026 in Review

Councilmark Asset Management held its AbbVie (ABBV) position steady in Q3 2026 at 11,137 shares worth $2.91M. The position accounts for 1.5% of the portfolio, ranked #18.

Councilmark Asset Management first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Councilmark Asset Management held 11,137 shares of AbbVie worth $2.91M as of Q3 2026.
  • Councilmark Asset Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 1.5% of Councilmark Asset Management's portfolio in Q3 2026, its #18 holding.
  • Councilmark Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Councilmark Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.